|
India Striving to Become A Pharmaceutical Outsourcing Hub
GV Prasa, CEO, Dr Reddys Laboratories, at the 13th Annual Pharmaceutical
Conference organized in London by the Economist told the delegates that
the landscape of drug discovery and development is fast changing in
India.
Talking about the future of Indian companies operating in the field
of contract research and manufacturing, Prasa said the attempts made by
firms to make more value across the drug discovery and development chain
will result in alliances that provide these firms with critical mass and
scale to take their drugs from labs to the market.
In particular, many large Indian players who used to deal in
generics-only have started to develop their own R&D programs and several
of these will certainly diversify their operation to offer discovering
services on contract basis also as experience, skills and capacity rise.
Some small players like Advinus Therapeutics, Connexios, Aurigene
Discovery, and GVK Lifesciences are already offering preclinical
contract services in India.
Indian drug manufacturers are putting high stakes on worldwide
pharmaceutical outsourcing for their future growth. One estimate
predicts worldwide pharmaceutical outsourcing to stand at a whooping $35
Billion. Asian market is eyeing on a significant share of it. Portion of
India in the world pharmaceutical outsourcing market is expected to
surge substantially to $1 Billion from the existing level of $400
Million.
RNCOS report Indian Biotechnology Market Outlook (2006) says that
Biopharma industry, consisting of therapeutics, vaccines, and other
related products, will come out as a critical segment of the Indian
biotech sector. Following a growth rate of 28.09% from 2005, the Indian
biotech sector is anticipated to become a US$ 5 Billion market by 2010
end.
The market research report also highlights the total market size,
trends in Indian biotech industry, industry performance, and market
segmentation. Apart from this, the report provides an in-depth analysis
on industrial biotech market, performance of industrial biotech
companies, and investments in Indian biotechnology sector. The report
brings forth the strengths and weaknesses of the Indian biotech market
into focus and discusses all the nitty-gritty of this sector.
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm.
It has a team of industry experts who analyze data collected from
credible sources. They provide industry insights and analysis that helps
corporations to take timely and accurate business decision in today's
globally competitive environment.
For more information visit:
http://www.rncos.com/Report/Biotech14.htmm
Current Industry News:
http://www.rncos.com/blog
Would you like to see your news and articles here? GO>>
Disclaimer: The views and opinions expressed in the research
published are those of the individual companies and writers and
not necessarily those of Investorideas.com®, or any of the
industry sector portals . At the time of publication, writers
may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot
assure accuracy of the research presented. Investors are
encouraged to research and verify facts and under no
circumstances is Investorideas.com® endorsing the content as a
recommendation to buy or sell stock.
|
Get Great Investing Ideas